Beck Mack & Oliver’s Edwards Lifesciences EW Stock Holding History

Beck Mack & Oliver’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Hold	15,120	–	–	0.03%	104
2026 Q1	$1.21M	Hold	15,120	–	–	0.03%	107
2025 Q4	$1.29M	Hold	15,120	–	–	0.02%	105
2025 Q3	$1.18M	Hold	15,120	–	–	0.02%	104
2025 Q2	$1.18M	Hold	15,120	–	–	0.02%	101
2025 Q1	$1.1M	Hold	15,120	–	–	0.02%	105
2024 Q4	$1.12M	Hold	15,120	–	–	0.02%	100
2024 Q3	$998K	Hold	15,120	–	–	0.02%	109
2024 Q2	$1.4M	Hold	15,120	–	–	0.03%	93
2024 Q1	$1.44M	Hold	15,120	–	–	0.03%	94
2023 Q4	$1.15M	Hold	15,120	–	–	0.03%	101
2023 Q3	$1.05M	Hold	15,120	–	–	0.03%	96
2023 Q2	$1.43M	Hold	15,120	–	–	0.04%	91
2023 Q1	$1.25M	Hold	15,120	–	–	0.04%	94
2022 Q4	$1.13M	Hold	15,120	–	–	0.03%	101
2022 Q3	$1.25M	Hold	15,120	–	–	0.04%	96
2022 Q2	$1.44M	Hold	15,120	–	–	0.04%	97
2022 Q1	$1.78M	Hold	15,120	–	–	0.04%	95
2021 Q4	$1.96M	Hold	15,120	–	–	0.05%	95
2021 Q3	$1.71M	Hold	15,120	–	–	0.04%	95
2021 Q2	$1.57M	Hold	15,120	–	–	0.04%	95
2021 Q1	$1.26M	Hold	15,120	–	–	0.04%	101
2020 Q4	$1.38M	Hold	15,120	–	–	0.05%	97
2020 Q3	$1.21M	Hold	15,120	–	–	0.04%	96
2020 Q2	$1.04M	Hold	15,120	–	–	0.04%	103
2020 Q1	$951K	Hold	15,120	–	–	0.04%	101
2019 Q4	$1.18M	Hold	15,120	–	–	0.04%	105
2019 Q3	$1.11M	Hold	15,120	–	–	0.04%	103
2019 Q2	$931K	Sell	15,120 -1,200	-7%	-$72.6K	0.03%	119
2019 Q1	$1.04M	Buy	16,320 +1,200	+8%	+$68.5K	0.04%	110
2018 Q4	$772K	Hold	15,120	–	–	0.03%	128
2018 Q3	$877K	Hold	15,120	–	–	0.03%	134
2018 Q2	$734K	Hold	15,120	–	–	0.02%	138
2018 Q1	$703K	Hold	15,120	–	–	0.02%	135
2017 Q4	$568K	Hold	15,120	–	–	0.02%	146
2017 Q3	$551K	Hold	15,120	–	–	0.02%	149
2017 Q2	$596K	Hold	15,120	–	–	0.02%	146
2017 Q1	$474K	Hold	15,120	–	–	0.02%	159
2016 Q4	$472K	Hold	15,120	–	–	0.02%	156
2016 Q3	$608K	Hold	15,120	–	–	0.02%	153
2016 Q2	$503K	Hold	15,120	–	–	0.02%	191
2016 Q1	$445K	Hold	15,120	–	–	0.02%	195
2015 Q4	$398K	Hold	15,120	–	–	0.01%	207
2015 Q3	$358K	Hold	15,120	–	–	0.01%	238
2015 Q2	$359K	Hold	15,120	–	–	0.01%	254
2015 Q1	$359K	Hold	15,120	–	–	0.01%	263
2014 Q4	$321K	Hold	15,120	–	–	0.01%	276
2014 Q3	$257K	Hold	15,120	–	–	0.01%	307
2014 Q2	$216K	Buy	+15,120	New	+$205K	﹤0.01%	338

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Beck Mack & Oliver's EW Position: Q2 2026 in Review

Beck Mack & Oliver held its Edwards Lifesciences (EW) position steady in Q2 2026 at 15,120 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #104.

Beck Mack & Oliver first reported a position in EW in Q2 2014 and has held it in 49 quarters since. The position peaked at $1.96M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Beck Mack & Oliver held 15,120 shares of Edwards Lifesciences worth $1.37M as of Q2 2026.
Beck Mack & Oliver left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.03% of Beck Mack & Oliver's portfolio in Q2 2026, its #104 holding.
Beck Mack & Oliver first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 49 quarters since.
Beck Mack & Oliver's Edwards Lifesciences position peaked at $1.96M in Q4 2021.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.